Company,Exchange,Drug_Name,FDA_Scientific_Name,Date,Classification,Sentiment_Score,Confidence_Score,Sources,Significance_Score,Title,Summary,Source_Type,Search_Query,Event_Trading_Date,Market_Model_Alpha,Market_Model_Beta,Day_-5_Simple,Day_-5_Log,Day_-4_Simple,Day_-4_Log,Day_-3_Simple,Day_-3_Log,Day_-2_Simple,Day_-2_Log,Day_-1_Simple,Day_-1_Log,Day_0_Simple,Day_0_Log,Day_+1_Simple,Day_+1_Log,Day_+2_Simple,Day_+2_Log,Day_+3_Simple,Day_+3_Log,Day_+4_Simple,Day_+4_Log,Day_+5_Simple,Day_+5_Log,Cumulative_Simple_-5_to_-1,Cumulative_Log_-5_to_-1,Cumulative_Simple_+1_to_+5,Cumulative_Log_+1_to_+5
Sun Pharma,NSE,Advair,Advair,2016-03-15,Good,0.0,0.0454545454545454,https://example.com/sunpharma-advair-approval,0.551059089316553,Sun Pharma Receives FDA Approval for Generic Advair Diskus,Sun Pharmaceutical Industries announces FDA approval for generic version of Advair Diskus inhalation powder.,Comprehensive Sample Data,Sun Pharma FDA Approval,2016-03-15,-0.00028990717421791755,1.1820156359044447,0.015099666052338348,0.015097462373464349,-0.006309680764521743,-0.006313262538457143,0.00257973307187607,0.0025681516468886697,0.0036205494961136972,0.003613936107158597,-0.0051125760245295405,-0.005136564955433641,0.005398277943980009,0.0051505307200939085,-0.006213433086974702,-0.006252174154072203,0.0018834700239307115,0.0018313971994462115,-0.009775872648688993,-0.009869189494753395,0.006224520364047477,0.005915633915607777,0.022761817299509803,0.022714655014433503,0.009877691831276833,0.009829722633620828,0.014880501951824297,0.014340322480661895
Sun Pharma,NSE,Unknown Drug,Unknown Drug,2017-05-25,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMimAFBVV95cUxNOGo4alpDaEpJOXJocDNWclhPZjdLY2xiQ0lLWGhqaHRKc2MxWjZSQUpabUV5VE9heWhaay1XelgyVmVIVkZIT3dabmc3cHJyWHlGYjd2VVMzel9wbHFyeVdNVTRGenA4NjZYN3lpVG9ldFhPT1RyV3g5UXh1emY5bGFWM1kzdzlPWVMtZnNXTVV0Q0Z1SVh6WQ?oc=5,0.5558065785306446,Problems at Sun Pharma plant trip up drug approval - BioPharma Dive,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNOGo4alpDaEpJOXJocDNWclhPZjdLY2xiQ0lLWGhqaHRKc2MxWjZSQUpabUV5VE9heWhaay1XelgyVmVIVkZIT3dabmc3cHJyWHlGYjd2VVMzel9wbHFyeVdNVTRGenA4NjZYN3lpVG9ldFhPT1RyV3g5UXh1emY5bGFWM1kzdzlPWVMtZnNXTVV0Q0Z1SVh6WQ?oc=5"" target=""_blank"">Problems at Sun Pharma plant trip up drug approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioPharma Dive</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2017-05-25,-0.00028990717421791755,1.1820156359044447,0.013415986126601605,0.013405042778313205,0.006207000587606742,0.006206252061239441,-0.006016160188017075,-0.006216902230446476,-0.005224021343197903,-0.006075184383027309,0.021736303701167234,0.021585597284670334,-0.015989295102807905,-0.016187969224798607,-0.02439749663029755,-0.02523633756294225,-0.07368550322081485,-0.08080064898962955,-0.0008180556415385478,-0.0008753641953324481,-0.01662201264782678,-0.01670204524406728,0.004115579349330695,0.004048095498522595,0.030119108884160604,0.02890480551074919,-0.11140748879114704,-0.11956630049344892
Sun Pharma,NSE,Unknown Drug,Unknown Drug,2017-10-17,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMitgFBVV95cUxOVG5oR3NhOFZYSlVXcjRjWFMtMHl1YzNabFRnTzFCVGlyRW9iakRJQ0x1QS1NNVVwYmplTW14M2lWUG5oTzUtU0NQdVRDajdhc2NhQTRvWndLWE8wcEduYjVpbnRPUWdpTnd5ZjZkRVV5Tkh2SWx5U1RnZXJZUDAwRHRGRXhfaFp0Qmt5QUQxV3lHblFnUHF6ak05ZU91OU5Xa1hZMXg3TFRwRWhZYUtHemhiRkQ5Zw?oc=5,0.5136874645158336,India’s Sun Pharma says its Dadra manufacturing plant gets FDA clearance - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxOVG5oR3NhOFZYSlVXcjRjWFMtMHl1YzNabFRnTzFCVGlyRW9iakRJQ0x1QS1NNVVwYmplTW14M2lWUG5oTzUtU0NQdVRDajdhc2NhQTRvWndLWE8wcEduYjVpbnRPUWdpTnd5ZjZkRVV5Tkh2SWx5U1RnZXJZUDAwRHRGRXhfaFp0Qmt5QUQxV3lHblFnUHF6ak05ZU91OU5Xa1hZMXg3TFRwRWhZYUtHemhiRkQ5Zw?oc=5"" target=""_blank"">India’s Sun Pharma says its Dadra manufacturing plant gets FDA clearance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2017-10-17,-0.00028990717421791755,1.1820156359044447,-0.03345239947503421,-0.03348379937561131,0.007294376653223708,0.007291994362699608,0.009736159539029579,0.00941239105535898,0.00031916789198133295,0.0002785211448978319,0.002474162994623521,0.0021721137454592185,-0.00836081695356215,-0.008361754397012148,-0.0042013922461626805,-0.00428391852559408,0.0033192404760581766,0.003285122983512176,0.021190496091947484,0.021153047910040683,-0.009541953672066795,-0.009600970953988996,-0.011399803390158612,-0.011626440208482311,-0.013628532396176066,-0.014328779067195666,-0.0006334127403824254,-0.001073158794512528
Sun Pharma,NSE,Unknown Drug,Unknown Drug,2017-11-08,Bad,0.35,0.0909090909090909,https://example.com/sunpharma-warning-letter,0.4847903737278123,FDA Issues Warning Letter to Sun Pharma Halol Facility,FDA issues warning letter to Sun Pharma for current good manufacturing practice deficiencies at Halol facility.,Comprehensive Sample Data,Sun Pharma FDA Warning Letter,2017-11-08,-0.00028990717421791755,1.1820156359044447,0.003572668406538024,0.0035436685822084237,-0.011827476473974391,-0.01218244532492269,-0.041440955674136234,-0.041678809998691835,-0.01151953549612155,-0.011687772174777447,-0.0041757646859298635,-0.004496899288713965,0.017403455537223812,0.017218953080275712,-0.005948174955877124,-0.005974595447978624,0.007540614384726644,0.007475919565203444,0.01913735523341329,0.01909794636462929,0.007486359696371599,0.007411262706295298,-0.04869861257563743,-0.04954922382354863,-0.06539106392362401,-0.06650225820489751,-0.02048245821700302,-0.021538690635399222
Sun Pharma,NSE,Ilumya,Ilumya,2018-03-21,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMiigJBVV95cUxPdmJPRzlMdExGZmJKQ1FES2NERFE2U1RDem5qaVdPdm9IdnhkbTF6bUk2b2tLeHJqdXh6Vkw3aUtiQWNFQ3NzX3p2RHdPM3NiV1M5NlBlem5tUkV1TUVfcGxpTFhvRHM0dVNxM0E1dXJFM3ZZdmdvWDcxZ0FvMkFsYmVSYmNQWGlHQnBmSEZjUWtsak9aYWlETFE4d1k0TXJXcEtxZ2ZDVi1SanBNSWRBQXltWFFKbzduTVJHNTFoV05DLVZVX29mSG5wZnpJYzhsZGtJVU9ncGhoZ2d0NU5WdGdra0RsckFKbzZveWZid0ttcUY3eTkxVERGaUgzY21tUmVRVUxHbnBIUQ?oc=5,0.5420702332299816,Sun Pharma Announces U.S. FDA Approval of ILUMYA™ (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMiigJBVV95cUxPdmJPRzlMdExGZmJKQ1FES2NERFE2U1RDem5qaVdPdm9IdnhkbTF6bUk2b2tLeHJqdXh6Vkw3aUtiQWNFQ3NzX3p2RHdPM3NiV1M5NlBlem5tUkV1TUVfcGxpTFhvRHM0dVNxM0E1dXJFM3ZZdmdvWDcxZ0FvMkFsYmVSYmNQWGlHQnBmSEZjUWtsak9aYWlETFE4d1k0TXJXcEtxZ2ZDVi1SanBNSWRBQXltWFFKbzduTVJHNTFoV05DLVZVX29mSG5wZnpJYzhsZGtJVU9ncGhoZ2d0NU5WdGdra0RsckFKbzZveWZid0ttcUY3eTkxVERGaUgzY21tUmVRVUxHbnBIUQ?oc=5"" target=""_blank"">Sun Pharma Announces U.S. FDA Approval of ILUMYA™ (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2018-03-21,-0.00028990717421791755,1.1820156359044447,-0.004679275868141864,-0.004698050519629964,-0.0007827791267165391,-0.0008075200199339399,0.001212096942217647,0.0008695499724576464,0.002725089614336866,0.002667059984966866,0.00877883124780305,0.008533716134581048,-0.0045827940939420705,-0.0046178836260218695,0.011288855743913133,0.011259128662444834,0.005776982407706108,0.005706788487454708,-0.006531083724911858,-0.006532350393212658,-0.017595999462432798,-0.017603109602636398,-0.0013037585505390123,-0.0015023634463284148,0.00725396280949916,0.006564755552441657,-0.008365003586264427,-0.00867190629227793
Sun Pharma,NSE,Pharma Receives Fda,Pharma Receives Fda,2018-08-16,Good,-0.0444444444444444,0.0454545454545454,https://news.google.com/rss/articles/CBMihgFBVV95cUxPTzd2NW95SUFndGdGV3NSNGJqWl81WXMxNjR1RXduNkRtRlZpMHg5RmpVMXVwT2k3QmtQeWhzcnJ4TWtkNDkyd25Pd0pGSnRweXZ5T20tVG80a3NENmtoWTF0NHBrRWM3NmkzMGlDX0c3X3k0VzBIM0FJTkF5Zjh6YzlGaWVmQQ?oc=5,0.567738191269955,Sun Pharma receives FDA approval for dry eye drug - BioPharma Dive,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxPTzd2NW95SUFndGdGV3NSNGJqWl81WXMxNjR1RXduNkRtRlZpMHg5RmpVMXVwT2k3QmtQeWhzcnJ4TWtkNDkyd25Pd0pGSnRweXZ5T20tVG80a3NENmtoWTF0NHBrRWM3NmkzMGlDX0c3X3k0VzBIM0FJTkF5Zjh6YzlGaWVmQQ?oc=5"" target=""_blank"">Sun Pharma receives FDA approval for dry eye drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioPharma Dive</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2018-08-16,-0.00028990717421791755,1.1820156359044447,0.01257090938591763,0.012542565555981829,-0.0038166359110114517,-0.0038265334867189516,-0.010364042526068585,-0.010839989528643585,0.0015185483732554697,0.0013607555687396682,0.022343397025158737,0.020181141469442637,-0.00016980614447729275,-0.0006035802908312925,0.006400837305395693,0.006382112297276092,-0.008235748848579957,-0.008246163855598957,-0.001300477558430076,-0.0014038644003383748,-0.004614842019751826,-0.004637113057064826,-0.0025051970626969126,-0.002624997059972713,0.0222521763472518,0.0194179395788016,-0.01025542818406308,-0.010530026075698778
Sun Pharma,NSE,Xelpros,Xelpros,2018-09-14,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMihAJBVV95cUxPYlRIRkZFZzEwRGJFeHFySVdOZXpjOHlNUDdFMW9CbU4wa2lzYzZfMHdxY2lwTTNiS05RMksyUm9QYUp6ZDVZOE94M1FOV2htbzdSWDFDZDBrQkJzR2R5ZTA1d2l6dkRFdXpzakU1Y2ZsZlRvUVVXRkViWlN1THZ4N1Z4NFc4S2NMSUREaUlvRWM1RUQtTjFQck5hUkZNQmJpVk9TclFSb3ZsVzlEbUZjZjY2YllQVGJmZy1mUGhnZ2tjQk4wRmVZVnJVNGFwLWNYMVdHckNTOTVNb2tVekw1MFZ6YTc0Rm1ZeVhuYlVRVmVPVXFHblhSbXh2UW12VjA3NTc3RA?oc=5,0.560388403384169,Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension - Business Wire,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxPYlRIRkZFZzEwRGJFeHFySVdOZXpjOHlNUDdFMW9CbU4wa2lzYzZfMHdxY2lwTTNiS05RMksyUm9QYUp6ZDVZOE94M1FOV2htbzdSWDFDZDBrQkJzR2R5ZTA1d2l6dkRFdXpzakU1Y2ZsZlRvUVVXRkViWlN1THZ4N1Z4NFc4S2NMSUREaUlvRWM1RUQtTjFQck5hUkZNQmJpVk9TclFSb3ZsVzlEbUZjZjY2YllQVGJmZy1mUGhnZ2tjQk4wRmVZVnJVNGFwLWNYMVdHckNTOTVNb2tVekw1MFZ6YTc0Rm1ZeVhuYlVRVmVPVXFHblhSbXh2UW12VjA3NTc3RA?oc=5"" target=""_blank"">Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Wire</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2018-09-14,-0.00028990717421791755,1.1820156359044447,-0.011692987747802228,-0.011901592248918225,-0.020584409533794753,-0.020775305550368554,0.000282139361699206,-0.0005199014089895884,-2.379063707681761e-06,-7.389874514718286e-05,0.016538647794850828,0.01606987412475963,-0.00783151027421448,-0.00810612130763188,-0.00953636823767988,-0.00987255695423488,-0.017820217208271386,-0.017836672420948888,0.008075282257852081,0.008026762789524583,-0.010303317247428759,-0.010537797578241559,-0.003094702823058711,-0.003243784919572513,-0.01545898918875463,-0.01720082382866392,-0.03267932325858665,-0.03346404908347326
Sun Pharma,NSE,Odefsey,Odefsey,2019-05-22,Good,0.0,0.0454545454545454,https://example.com/sunpharma-odefsey-approval,0.5607934695485662,Sun Pharma Gets FDA Approval for Odefsey Generic,Sun Pharma receives FDA approval for generic version of Odefsey tablets for HIV treatment.,Comprehensive Sample Data,Sun Pharma FDA Approval,2019-05-22,-0.00028990717421791755,1.1820156359044447,-0.015452266529002699,-0.015723859465628997,0.00971666292611393,0.009695838009534729,0.006916532847498479,0.006884343838387378,0.027401628789935076,0.027344200490250374,-0.015168768430302265,-0.015232475775555167,0.02034125667981678,0.019894023762468377,-0.0026571720279287524,-0.002851537542264252,-0.01809462710462212,-0.018117512130883816,-0.012162538194105671,-0.012164884769749171,0.005128019512582921,0.005115163200468321,0.0221976569568235,0.0218455647006152,0.01341378960424252,0.012968047096988317,-0.005588660857250124,-0.006173206541813716
Sun Pharma,NSE,Unknown Drug,Unknown Drug,2020-08-10,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMivAFBVV95cUxQZlBmTDVGM0k3TGctSENsT2Mwc1QwdjVtZFZTTUI0Nkx1Y0lVOS00ellDUWh5M0tZcUk3cWdma1FiSG81TFpreDJaeHZtSkF5bWhfQzd1Tktfc2Fxb2ZpbXdNM2JHRGRsT0pPRnJlb2c4TEFXVEdRRnhnUTU0TjlBSTBIZV9tbWtWSmdqaXo1UjZ1eGdwelZZb2ZEaGp3MFdpVWRiRERkLVM0emJZcjh2cDA2ZXdraVEyYU5IaQ?oc=5,0.4978856332403505,"Sun Pharma, Lupin launch U.S. recalls of blood pressure, epilepsy meds - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQZlBmTDVGM0k3TGctSENsT2Mwc1QwdjVtZFZTTUI0Nkx1Y0lVOS00ellDUWh5M0tZcUk3cWdma1FiSG81TFpreDJaeHZtSkF5bWhfQzd1Tktfc2Fxb2ZpbXdNM2JHRGRsT0pPRnJlb2c4TEFXVEdRRnhnUTU0TjlBSTBIZV9tbWtWSmdqaXo1UjZ1eGdwelZZb2ZEaGp3MFdpVWRiRERkLVM0emJZcjh2cDA2ZXdraVEyYU5IaQ?oc=5"" target=""_blank"">Sun Pharma, Lupin launch U.S. recalls of blood pressure, epilepsy meds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2020-08-10,-0.00028990717421791755,1.1820156359044447,-0.016498887753659812,-0.01677066192865281,0.0002681506390875485,0.00010115857905514808,0.008389126095256369,0.00838910817626307,0.006442636128162947,0.006422057957782248,0.0016741280244815335,0.0016035205277531335,-0.0020226237783000853,-0.0025889530723300844,0.009830198499315549,0.00981689940997385,0.007573187645145016,0.0074363923823770155,-0.007920490089233916,-0.008151232370234915,0.009211291207676968,0.009008842743296766,0.0007297174127714381,0.0007137198914707382,0.0002751531333285862,-0.0002548166877992114,0.019423904675675056,0.018824622056883455
Sun Pharma,NSE,Anti,Anti,2021-12-16,Good,0.1999999999999999,0.0454545454545454,https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYzJ3WjhvZWp6c2tha09DU1VncFNpLXA1TWpwanNyVWRLS2VHRzFKVUxfUWNJb3V4VjR3ckZ2RVdZSnc2Y2x5ajVtQjV0VzFzYkpfcmV5bFU0ZjQyaVd4VFY4RmgxSkZIYy16MVh1YXVhU3F2dk9EUHJSeFB5Vm93LU9aTHZDSTFvYVY2THg1Z0xELVJGVmlCTWs1bkNBbkd5QXlsVkpWdE1vQdIBrwFBVV95cUxPSTI0UXZaNF9pczE0TGMwS3Z1N1c2MGJIcHdVN2RLTGVfbTNUY3k3MjNJdkM3a2VoQnppbjgwU3JQX2o2NnBCWGs4dEdqVUhibjNlUUpUYWQtMkF1eU5TV1BPLVZEQWFabDZMdnpDb1RMNHpoMjlWVTRPaVdRemVlVWtuOVVwSnlPMkEyUkJnNUxxeFlNYkhvU29qU2x3TmdxaHJmcGY5QmFaWjdIQkFn?oc=5,0.548533405928448,Sun Pharma Wins U.S. FDA Approval For Anti-Fungal Injection — Analyst Take - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYzJ3WjhvZWp6c2tha09DU1VncFNpLXA1TWpwanNyVWRLS2VHRzFKVUxfUWNJb3V4VjR3ckZ2RVdZSnc2Y2x5ajVtQjV0VzFzYkpfcmV5bFU0ZjQyaVd4VFY4RmgxSkZIYy16MVh1YXVhU3F2dk9EUHJSeFB5Vm93LU9aTHZDSTFvYVY2THg1Z0xELVJGVmlCTWs1bkNBbkd5QXlsVkpWdE1vQdIBrwFBVV95cUxPSTI0UXZaNF9pczE0TGMwS3Z1N1c2MGJIcHdVN2RLTGVfbTNUY3k3MjNJdkM3a2VoQnppbjgwU3JQX2o2NnBCWGs4dEdqVUhibjNlUUpUYWQtMkF1eU5TV1BPLVZEQWFabDZMdnpDb1RMNHpoMjlWVTRPaVdRemVlVWtuOVVwSnlPMkEyUkJnNUxxeFlNYkhvU29qU2x3TmdxaHJmcGY5QmFaWjdIQkFn?oc=5"" target=""_blank"">Sun Pharma Wins U.S. FDA Approval For Anti-Fungal Injection — Analyst Take</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2021-12-16,-0.00028990717421791755,1.1820156359044447,0.010158133320344744,0.010153924154939244,0.002439856890749807,0.0024376426706162074,-0.0059417093919938175,-0.005943055954184418,-0.008555185049457303,-0.008592284838957404,0.022346173085615033,0.02203396618345793,0.005073191085613077,0.004977921940670177,0.021402978337101822,0.02138572119529872,-0.004645914168735232,-0.004667145752671931,0.006726550432746611,0.00654622604933091,0.002183516670320417,0.0018920169146395167,-0.023063529519160325,-0.023083663200304024,0.020447268855258466,0.02009019221587156,0.002603601752273293,0.002073155206293191
Sun Pharma,NSE,Unknown Drug,Unknown Drug,2023-02-14,Bad,-0.0971428571428571,0.0454545454545454,https://news.google.com/rss/articles/CBMirwFBVV95cUxPa0NMc1l1WXRJX1ljb1RrVHQyNEtlYTBsWDM5TlY4d3FKc0lTVkUyNmdVcmsxZnkxVU5wZUpJRnBEZzl5cUgyejlPLWkzZ01pNzdrdFNkX01vVzhNVTZPSFNnSk1TRkJ4eFNrdXFYc0F0RUtGNXJqc0ZuNGxiRWs2R0xpUEYtUXoyb0Nra0tDRnVoN19jejFmTThqLWNRcWZzQ0pmVWVfc0RhcTJ2alpj?oc=5,0.4670923299870235,Sun Pharma recalls generic for high blood pressure after failed FDA lab test - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPa0NMc1l1WXRJX1ljb1RrVHQyNEtlYTBsWDM5TlY4d3FKc0lTVkUyNmdVcmsxZnkxVU5wZUpJRnBEZzl5cUgyejlPLWkzZ01pNzdrdFNkX01vVzhNVTZPSFNnSk1TRkJ4eFNrdXFYc0F0RUtGNXJqc0ZuNGxiRWs2R0xpUEYtUXoyb0Nra0tDRnVoN19jejFmTThqLWNRcWZzQ0pmVWVfc0RhcTJ2alpj?oc=5"" target=""_blank"">Sun Pharma recalls generic for high blood pressure after failed FDA lab test</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2023-02-14,-0.00028990717421791755,1.1820156359044447,-0.012569363823949055,-0.012708066334747154,-0.005898970472949018,-0.005997665252004618,-0.001859217632411773,-0.0018780236511044728,0.0004033684890075098,0.0004033487253104098,0.010859389576740746,0.010822676783017647,-0.001418302179768017,-0.0014535470334919162,-0.01021403426103029,-0.01027806574128559,-0.007674643099262556,-0.007674674657098056,0.011376942815039773,0.011319264925862573,0.011468234018059447,0.011468228873616947,-0.007637417870534505,-0.007722695437705106,-0.009064793863561588,-0.009357729729528187,-0.0026809183977281317,-0.002887942036609233
Sun Pharma,NSE,Its Product,Its Product,2023-08-21,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMiwwFBVV95cUxOd0NoMDhJT2dKdDVXUVl5RFBhZ0pqZUZfS19fMHRfUnRkdE5lSkhIREdwRUdPSmNTcTB4b0hyZEtuQzh5c1hCcEozcWp6T3Z6bVJqT3dzdi1fX0ZpTUE5TW1rcERaVy1QbTdndzNwX3R1UDcxRWdaNlVRNm0zWFUtV0NIVzI1cW9icWpUYXRUTTFULVRzY1g0cERzNWhFa0ZpRXpTbEVhcEs5ZjZ2U28wWlBXbzdJUy1tWHBQYl96VHJwWWM?oc=5,0.4646887627091707,Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOd0NoMDhJT2dKdDVXUVl5RFBhZ0pqZUZfS19fMHRfUnRkdE5lSkhIREdwRUdPSmNTcTB4b0hyZEtuQzh5c1hCcEozcWp6T3Z6bVJqT3dzdi1fX0ZpTUE5TW1rcERaVy1QbTdndzNwX3R1UDcxRWdaNlVRNm0zWFUtV0NIVzI1cW9icWpUYXRUTTFULVRzY1g0cERzNWhFa0ZpRXpTbEVhcEs5ZjZ2U28wWlBXbzdJUy1tWHBQYl96VHJwWWM?oc=5"" target=""_blank"">Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2023-08-21,-0.00028990717421791755,1.1820156359044447,0.0005669329984311754,0.0004438962585197742,0.00374373091028946,0.0037423245651965597,-0.000968412980438928,-0.001002564932212728,0.001357631935050025,0.001357126530946825,-0.0081542359473579,-0.008191846578297399,-0.002724179915577209,-0.002726602427526409,-0.0014452542457053076,-0.0014452629453384075,-0.009467109365051938,-0.009541835350722838,0.00020844768222929005,0.00019686460424539042,0.010031896216946088,0.00997390761393849,-0.0005628031767213378,-0.0006092761421565389,-0.0034543530840261674,-0.003651064155846968,-0.0012348228883032036,-0.001425602220033904
Sun Pharma,NSE,Deuruxolitinib,Deuruxolitinib,2023-10-06,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMizwFBVV95cUxQZzB3WWF2OURNM0hWOFNuUE5iSG85cVNOR2EwU19yQnVsM3hVZlZxaWtnSXMwbkxNa25MS1B3TkhEZVpNdXNvS1JnWk53NmppdjNOUHo3bnZKYUl3MDB4dFVJRDNWX3RudGw3R29RWVBwcldkZHVFSUZUQUVwWTNlV2w0czdPNDByOWR1X3JmNUFIUmRCQ2pLczNIQ3N4S1NLYzdNbnZtV01jTE1ocGx2OGRHazhBVmdPVkc1VDFjMFB4R2JvU05zUFZ2WnFtbVXSAdQBQVVfeXFMTS1JVDV4YWVfWm45b0poNG82S20telNIQ2hkUWxFdnp5bFg5VDJIaGtlQnpHVUJlV3RiVldldE55NmFxeVpiUkJhWTZPdmo5QmdYMzJEbEVkRDdJVnNETlUwUld4cUd1dG8xaVloVTR2cFBxeGNWMURldVBaaE9aSmpSQXo2cVNhYkU2NnduU1Z0aGxOOTdzWDhRalZocmptbVRWRHFLdHJ6R3Z4bVprS3c2UmJ6VXRkc2lhenpsSVZMZEVDYndNamVWQ3dVbmp5LXVlem8?oc=5,0.4908383033607583,US FDA approves NDA for Sun Pharma's alopecia drug Deuruxolitinib - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA approves NDA for Sun Pharma's alopecia drug Deuruxolitinib</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2023-10-06,-0.00028990717421791755,1.1820156359044447,-0.0022986014154413627,-0.0023212195577989626,-0.004891224161289905,-0.005157865881877506,-0.0005933329283720028,-0.0007046194908244038,0.005428371968447362,0.0053075776360490615,0.00038233817644816367,0.0003735677187923633,0.0020242812829941873,0.0019975656901543874,-0.0009690347571259961,-0.0009761602388283961,0.007178017435060883,0.007173308235919983,-0.004140137459491766,-0.004142129581551366,-0.00031046746746124987,-0.00031153488933004974,0.021672076781214304,0.021585960922369002,-0.0019724483602077446,-0.0025025595756594477,0.023430454532196176,0.02332944444857917
Sun Pharma,NSE,Unknown Drug,Unknown Drug,2024-07-03,Bad,0.1333333333333333,0.0454545454545454,https://news.google.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?oc=5,0.4598404290175036,Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2024-07-03,-0.00028990717421791755,1.1820156359044447,-0.007729398248761073,-0.007785148437326273,-0.005714256918091994,-0.005719456118225294,-0.014022844578297208,-0.014027437131159406,-0.004365435646802461,-0.004365557326478261,0.0018848945402835098,0.0018815239632625099,-0.004462437083273101,-0.004483443948408601,0.006637683513100349,0.006517049847535348,-0.008362756615609805,-0.008385367919158004,-0.0014234691645399252,-0.0014528892887846253,0.012567026827922026,0.012395563902956827,0.010434163509176256,0.010399952909212754,-0.029947040851669222,-0.030016075049926722,0.0198526480700489,0.0194743094517623
Sun Pharma,NSE,Sun Pharma,Sun Pharma,2024-07-26,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMioAFBVV95cUxQU1dMdDgzdnVveTZ6Mjltd085b1hfUkRIc3FINjVQaTdESFNLbTNCQXJBTV8tcWh5UHAwSkJ5UEZaUlBobG5VdWtMLUZjeGNlN0VpNHlNb0xPNmtFYnNhbS1KWjlLaFpFTFRhTUJGY2g5dmdpZXBVeHZSekp3bUhSNzU3Y1JLYThwWkx0TkZ1YUwyYUswNGN5ZWVRVXA1bTZw?oc=5,0.5169476685207869,FDA approves Sun Pharma’s JAK inhibitor for alopecia - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxQU1dMdDgzdnVveTZ6Mjltd085b1hfUkRIc3FINjVQaTdESFNLbTNCQXJBTV8tcWh5UHAwSkJ5UEZaUlBobG5VdWtMLUZjeGNlN0VpNHlNb0xPNmtFYnNhbS1KWjlLaFpFTFRhTUJGY2g5dmdpZXBVeHZSekp3bUhSNzU3Y1JLYThwWkx0TkZ1YUwyYUswNGN5ZWVRVXA1bTZw?oc=5"" target=""_blank"">FDA approves Sun Pharma’s JAK inhibitor for alopecia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2024-07-26,-0.00028990717421791755,1.1820156359044447,0.0016047998246491828,0.0014744789977369846,-0.0006718448230660437,-0.0007423410859072437,-0.0017430502467407384,-0.0017831060173945385,-0.0031825118775949436,-0.0032441606575746434,4.3761455171993646e-05,-0.000358165120755205,0.009211201211815446,0.008796256234133246,0.012792668228239025,0.012778934780433224,-0.0026422884256871986,-0.002721876211316799,0.006539175573179151,0.006485144137474651,-0.0009313745683387339,-0.0009342923727982337,0.0002437078853038694,0.00019800795814787012,-0.003948845667580549,-0.004653293883894646,0.016001888692696115,0.015805918291940713
Sun Pharma,NSE,Gets Usfda Fast,Gets Usfda Fast,2024-09-06,Good,0.1142857142857143,0.0454545454545454,https://news.google.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?oc=5,0.4833265443055193,Sun Pharma-Moebius Medical anti-osteoarthritis pain drug gets USFDA fast track status - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMikAJBVV95cUxNNDdvc0Z3MjU3T3UwakRmSG4zUi12WkxpZjJEV2xQekFwSnAwZUFJOFRVRFdoSTRnTnU0LS1VdURySW1ZMnpUUkt1SFVqeERnd2xtZDdBQzNraFUxN2l3U0NGZXFxTEdlX1hldG45X2NELTVUdTVqQUFOUGNQRHVNRWxwU2NXZHJMSkxtSnM2N0JYMnZ0eldGRWVBV1dNOWQxcG9kM09ITW5Dd1ZNSllqXzdIZ1g1WGxsSTFIYWR6ay1CMWE3ZDJ2aEY2MGJOMHNYNzdSY3YwT2VYOWxGMzN0SHJsUGZoQm9KVmlIbGd3TjNWUHVYMTFLRW5oZFBUNW5pV1ZTUHNjMFZMRFRpMDdBddIBlgJBVV95cUxOYUZabFprOTRDOG14VGR0bUh2MzhQNkFVX0xtRU56MTZfaF94OHcxaVdVc095QVRub1RzaTJTb08zNUlkaDRaV2pNSFdvaWlsZll2SkVDUlJPSGEyREVXS29GRURTWlB6LU9QcmY4WXhLNERQM3hVR3NSVDZhTUNLR2RidkpKaWtwLWp6Q0w4dkYzY1RqZ0Zud2VDd3pDbXMyUGhNMUxfODZ2ZENOd0UydlVvZVhTNW5UNUpFZGRCSUhNNVpURlJCTHFQYnd1b3BaS2ZhLW1zNkZmdFVFVUFxX0k2NzUwNWhGblc1czdwd2R1VVRRLVptNEZTajZVVHE1aXhoNVJYQjhkZzJzUkxRZEhoZnpHZw?oc=5"" target=""_blank"">Sun Pharma-Moebius Medical anti-osteoarthritis pain drug gets USFDA fast track status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2024-09-06,-0.00028990717421791755,1.1820156359044447,-0.0018904362381249352,-0.0019676429793363363,0.0025965811601700722,0.0025916753748932726,0.0014805212422406948,0.0014775140206200951,-0.007788936218336696,-0.007857847950829196,-8.364681844183703e-05,-8.9662287187237e-05,0.010742516009247029,0.01074194574536783,-0.004053981653778167,-0.004055077688020667,-0.0039524255261809745,-0.003983930311530473,0.006945699494369005,0.006932780863654105,0.011403139606366129,0.01134658056999133,-0.0045886665015874165,-0.004608250099606617,-0.0056859168724927005,-0.005845963821839401,0.005753765419188576,0.005632103334487679
Sun Pharma,NSE,Sun Pharma,Sun Pharma,2025-05-16,Good,0.0909090909090909,0.0454545454545454,https://news.google.com/rss/articles/CBMilgFBVV95cUxORjZZeVBzSnVuLVpKMk1XazYydzNXV1RHak00X3JON2JYbmxZamZpRDZ0RHVCNldsUVdyN3RNMm1KMm8xTTZPNllzcjJjWnpzaEdpN3RlMkItX2s3aVZueXdhMHIzOW5VRnRzdUFXajdnd3BiMGJIMDN2Wm10andGWHp0dXRZQURtWGlwU2d4NEJ4WXN5WFE?oc=5,0.4856314019693515,FDA Approves Sun Pharma's New LED BLU-U Device for AK - Dermatology Times,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxORjZZeVBzSnVuLVpKMk1XazYydzNXV1RHak00X3JON2JYbmxZamZpRDZ0RHVCNldsUVdyN3RNMm1KMm8xTTZPNllzcjJjWnpzaEdpN3RlMkItX2s3aVZueXdhMHIzOW5VRnRzdUFXajdnd3BiMGJIMDN2Wm10andGWHp0dXRZQURtWGlwU2d4NEJ4WXN5WFE?oc=5"" target=""_blank"">FDA Approves Sun Pharma's New LED BLU-U Device for AK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Dermatology Times</font>",Google News Enhanced,"""Sun Pharma"" FDA approval",2025-05-16,-0.00028990717421791755,1.1820156359044447,-0.004568176774730896,-0.004649193728031097,-0.03150498276375169,-0.03208193299363538,-0.0005815710149157348,-0.0006148792016754355,-0.010971795930518925,-0.010983391529245025,0.005876483920512611,0.005704253132559711,-0.0006671313860975255,-0.0006716052382249255,-0.00016009385881739094,-0.00016377026151019125,0.0012597445338822372,0.001175209104138538,-0.0010124084871492283,-0.0011102388416665276,0.005242684970170014,0.005213929429919914,-0.011853014442988368,-0.01206443570026707,-0.04175004256340464,-0.04262514432002723,-0.006523087284902737,-0.0069493062693853375
Biocon,NSE,Unknown Drug,Unknown Drug,2017-05-10,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMilwFBVV95cUxOVzhoNE9pZmpHQjZCRERrRUc3dGNTZjRsYkV3Ykw2OVhNeTVlWFhISHJ0R01ZbzlJV1BuQ3czRW85LXBuTXdDdEdQUlBSQUJrTjBPbjJITk0tcjBjcm1SNmlUSS16czlkUjBHVnM5QUlxeW4zN1NRdHgxdHpQMVJPVWpSelhlS01CSDBYS3dOeVBJTnVhUkM0?oc=5,0.4598251973620654,Biocon downplays FDA Form 483 for Bangalore plant - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxOVzhoNE9pZmpHQjZCRERrRUc3dGNTZjRsYkV3Ykw2OVhNeTVlWFhISHJ0R01ZbzlJV1BuQ3czRW85LXBuTXdDdEdQUlBSQUJrTjBPbjJITk0tcjBjcm1SNmlUSS16czlkUjBHVnM5QUlxeW4zN1NRdHgxdHpQMVJPVWpSelhlS01CSDBYS3dOeVBJTnVhUkM0?oc=5"" target=""_blank"">Biocon downplays FDA Form 483 for Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Biocon"" FDA approval",2017-05-10,0.0006722960020706152,0.8531434796386115,-0.036011813194898074,-0.037298333835508374,0.012790830294605083,0.012550592325729883,-0.012506891834385133,-0.012667455810960133,0.008062460263051937,0.007932532217423337,-0.004955254782687168,-0.004979710310258867,-0.032666903284797766,-0.033481268261710065,-0.004876881701517281,-0.004883869260682681,-0.0158009529254752,-0.0159854706875147,0.010977392559483323,0.010521129648413525,-0.008961045927451707,-0.008977264746569607,-0.010377379430085995,-0.010457149766237395,-0.03262066925431335,-0.03446237541357416,-0.029038867425046862,-0.02978262481259086
Biocon,NSE,Of Amgen,Of Amgen,2017-10-10,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMimwFBVV95cUxPMVhKV0x1TlZBWjZlcWU3akVjTnJaWWh4dVZjc05PUHRlXzBLcmFLUUFPNFZSRWlsMDcxUEZhVEhBTEktam1hSmhzbjdULXd0ODFhajM1VW5RaWxCc1VRdzZkNFVzZ3lqYmxFOE5mS1Fha0VWZURPUEl2NTlmNTFWYXJmMWpiZk0wbWdEVlI3LUpRbFk4YVBXLW84SQ?oc=5,0.5070454545454546,Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPMVhKV0x1TlZBWjZlcWU3akVjTnJaWWh4dVZjc05PUHRlXzBLcmFLUUFPNFZSRWlsMDcxUEZhVEhBTEktam1hSmhzbjdULXd0ODFhajM1VW5RaWxCc1VRdzZkNFVzZ3lqYmxFOE5mS1Fha0VWZURPUEl2NTlmNTFWYXJmMWpiZk0wbWdEVlI3LUpRbFk4YVBXLW84SQ?oc=5"" target=""_blank"">Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Biocon"" FDA approval",2017-10-10,0.0006722960020706152,0.8531434796386115,0.009285766507221127,0.009180185016235926,-0.009585941832765385,-0.009621501819671585,0.010027728981767795,0.009955537898077495,0.006293759923269398,0.006092318199804797,-0.01894183407920473,-0.01912647519339743,0.05316502223840351,0.050658283514623606,0.0010816774571523417,0.0010697511284318414,-0.0001272705032342846,-0.00020169244208178422,0.002609924148888457,0.002604706013056057,-0.005245208831500656,-0.0053135433903209565,0.023138382597618103,0.022723958448182705,-0.0029205204997117956,-0.0035199358989507976,0.021457504868923963,0.02088317975726786
Biocon,NSE,Lantus,Lantus,2018-02-21,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMitgFBVV95cUxOY1VrZjAwc1g2NEwwZi14bGlucndBMnRmNFdxbFp6Z29LZ2ZodHdUdXp2cmlEYTZvTHlzTUhzQXI1djFNZkVBMFRNRHBScXVqbmRVd0pwcUJFa1dFRVRlSldkckd0VzZsWC04czBKa0NjeXJKd1pZV2FjLXZGWHE5bXo5MVFFelljbGF1ekl3eDY0akZiY1YtaHp1MDlqdzd5aDAyR2x4S1lGXzNSek5maXJlaGhEZw?oc=5,0.4271385663525883,Plant where Biocon and Mylan will produce their Lantus copy spanked with FDA Form 483 - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxOY1VrZjAwc1g2NEwwZi14bGlucndBMnRmNFdxbFp6Z29LZ2ZodHdUdXp2cmlEYTZvTHlzTUhzQXI1djFNZkVBMFRNRHBScXVqbmRVd0pwcUJFa1dFRVRlSldkckd0VzZsWC04czBKa0NjeXJKd1pZV2FjLXZGWHE5bXo5MVFFelljbGF1ekl3eDY0akZiY1YtaHp1MDlqdzd5aDAyR2x4S1lGXzNSek5maXJlaGhEZw?oc=5"" target=""_blank"">Plant where Biocon and Mylan will produce their Lantus copy spanked with FDA Form 483</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Biocon"" FDA approval",2018-02-21,0.0006722960020706152,0.8531434796386115,0.0028773233195877115,0.002841025958447412,-0.009020268070742164,-0.009058628175101164,0.0036402909372489954,0.003600975651752095,-0.004725172845821846,-0.005076696034625745,-0.023652274658226155,-0.02415276613221746,0.025187152572210297,0.0251087116771474,0.04591540331805717,0.04362742233179037,-0.011507765672282516,-0.011600966942229915,0.0032831810909843477,0.0032827980391031478,-0.007153808435269774,-0.0071981057425091755,0.01231575246040659,0.012250374975355392,-0.03088010131795346,-0.03184608873174486,0.04285276276189581,0.040361522661509816
Biocon,NSE,Biocon Gets Fda,Biocon Gets Fda,2019-12-03,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,0.5324652289895009,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Biocon"" FDA approval",2019-12-03,0.0006722960020706152,0.8531434796386115,0.015919540293381346,0.015675945108696247,0.02671712530240402,0.02568384716518752,0.018372502503561015,0.018039352369421814,0.004703909589647933,0.004676385707327033,0.020212702749373604,0.0201052023061139,0.0045358446798840065,0.004535783481381107,-0.005479433591686525,-0.005493167860143026,0.002936765552992901,0.002934580177175601,0.00869373766378745,0.00865886942949805,-0.0008812963614524953,-0.0008815356719981953,0.0011081983109644555,0.0011069889652070555,0.08592578043836792,0.08418073265674651,0.006377971574605786,0.006325735039739485
Biocon,NSE,Semglee,Semglee,2020-06-11,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,0.5412774935554061,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",Google News Enhanced,"""Biocon"" FDA approval",2020-06-11,0.0006722960020706152,0.8531434796386115,0.006399994915144765,0.005983205142337064,-0.009538943376008245,-0.009592233508060344,-0.008940321849370313,-0.009173327929697514,-0.01795058470082183,-0.01795113469924173,0.016578757864520257,0.016345648869108154,0.012146657201054602,0.012116910596175503,-0.00504133682687686,-0.00505683075710086,0.000757033626155458,0.0007316171502791584,-0.003305868270665991,-0.0033259355703559915,0.019882750613322717,0.019482404261022417,-0.005473163468264378,-0.0054893587327403785,-0.013451097146535366,-0.01438784212555437,0.006819415673670946,0.006341896351104345
Biocon,NSE,Lantus,Lantus,2021-06-11,Good,0.1,0.0454545454545454,https://example.com/biocon-semglee-biosimilar,0.5102688333040302,FDA Approves Biocon's Semglee as Biosimilar to Lantus,FDA approves Semglee (insulin glargine-yfgn) as biosimilar to Lantus developed by Biocon Biologics.,Comprehensive Sample Data,Biocon FDA Approval,2021-06-11,0.0006722960020706152,0.8531434796386115,0.0010916713573426466,0.0010915364315088466,0.008390197863357984,0.008332486695950384,0.019517249244353913,0.018937368601627015,0.008245685165147643,0.008232755369590143,0.01233826827617747,0.01202253761907287,-0.011098352545785508,-0.011098534166143308,-0.004441658321574501,-0.004467044566720001,0.0009034079744588207,0.0008963154662165206,-0.011097090714670882,-0.011254913680432781,-0.0010554100810644205,-0.0011209731138681206,-0.0014691450252307145,-0.0014694280816060145,0.04958307190637966,0.048616684717749256,-0.0171598961680817,-0.017416043976410396
Biocon,NSE,Semglee,Semglee,2021-07-29,Good,0.1999999999999999,0.0454545454545454,https://example.com/biocon-semglee-interchangeable,0.5122176094143278,FDA Approves Biocon's Semglee as First Interchangeable Biosimilar,"FDA approves Semglee as first interchangeable biosimilar insulin in the United States, developed by Biocon.",Comprehensive Sample Data,Biocon FDA Approval,2021-07-29,0.0006722960020706152,0.8531434796386115,-0.00959891638703227,-0.00960370668453147,-0.014045314787538298,-0.014118319676499395,-0.019499588555379716,-0.019739059822940216,0.01699693839252606,0.01666498491434006,0.010140598016823009,0.010124614505990809,-0.0018114592108758125,-0.0018139348459995123,-0.02461102933661495,-0.024660041292897252,0.0062850679884093015,0.006240721653295002,-0.010441006135867882,-0.010442618793866681,-0.00707229973709042,-0.00711775289427942,-0.004313154639471003,-0.004320242421097202,-0.016006283320601212,-0.016671486763640216,-0.04015242186063495,-0.04029993374884555
Biocon,NSE,Unknown Drug,Unknown Drug,2023-02-13,Bad,-0.3333333333333333,0.0454545454545454,https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5,0.4550700366906426,Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5"" target=""_blank"">Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Biocon"" FDA approval",2023-02-13,0.0006722960020706152,0.8531434796386115,0.02516027090206553,0.02461329535732133,-0.011689096467656972,-0.011783670616680272,0.011381415845283164,0.011030963828951563,-0.0016978989031331284,-0.0017054920654158284,-0.0037369944142930317,-0.0037424186300586315,-0.018433146037403016,-0.018619608408633415,-0.007431577050749363,-0.007499021482750364,0.01329054403671605,0.01320146355577885,0.01371013567006243,0.013513748189224828,-0.027564653498192093,-0.028499501322301994,-0.01317602653629146,-0.01339211636829346,0.019417696962265564,0.01841267787411816,-0.021171577378454435,-0.02267542742834214
Biocon,NSE,Unknown Drug,Unknown Drug,2023-10-09,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5,0.4806429728497933,FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Biocon"" FDA approval",2023-10-09,0.0006722960020706152,0.8531434796386115,-0.001350531513532035,-0.0015451234469223349,0.011241672862490962,0.011239987745870861,-0.014589222386602266,-0.015011672780326366,-0.002306695011455939,-0.002317868451198439,-0.0011052916335442097,-0.0011117702798147098,-0.014357607784439591,-0.014478956129688492,-0.007708824054411298,-0.007757069332837898,-0.007250101675439981,-0.007251983346267781,0.008328760169539297,0.008274127205617997,-0.016090930964906602,-0.016321874287413305,-0.0008867722374430162,-0.0008877185265294163,-0.008110067682643489,-0.008746447212390988,-0.0236078687626616,-0.023944518287430404
Biocon,NSE,Fda,Fda,2024-05-21,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5,0.5389115437152878,Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",Google News Enhanced,"""Biocon"" FDA approval",2024-05-21,0.0006722960020706152,0.8531434796386115,-0.00909830439867794,-0.00912833732931664,0.019418296326442458,0.01895753201851646,0.004614060821939291,0.004608899039904891,-0.015249034955429301,-0.015446024546314304,0.002940481208107396,0.002940427763457796,0.002617410131478675,0.002601102572446775,-0.004126934644559026,-0.004127581536570526,0.023830195268615566,0.023534478444285165,0.011425459837425562,0.011347734951114161,-0.007139969188156855,-0.007240128190748755,0.0014286848967608448,0.0013893997864438462,0.0026254990023819036,0.0019324969462482019,0.025417436170086093,0.024903903454523892
Biocon,NSE,Daptomycin Injection,Daptomycin Injection,2024-08-30,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5443678105900815,Biocon arm Biocon Pharma receives US FDA approval for Daptomycin injection - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm Biocon Pharma receives US FDA approval for Daptomycin injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",Google News Enhanced,"""Biocon"" FDA approval",2024-08-30,0.0006722960020706152,0.8531434796386115,-0.013991906025273285,-0.014087239763167286,0.003672474177339946,0.0036614971690475456,-0.00520956840075667,-0.005210571050350271,0.002288546394407941,0.002226315704831342,0.0015744111894420132,0.0015682566814875132,-0.0009835083922538918,-0.0010358726062631926,0.01522542153463157,0.015154296131969868,-0.002172034227000687,-0.002180576845351387,0.03334595293318289,0.032213177619637885,0.010652029422562263,0.010610934007482864,-0.016257083255432916,-0.01654731497369142,-0.011666042664840054,-0.011841741258151156,0.040794286407943116,0.03925051594004781
Biocon,NSE,Secures Us Fda,Secures Us Fda,2024-12-01,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5470454545454545,Biocon Biologics secures US FDA approval to commercialise YESINTEK - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval to commercialise YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",Google News Enhanced,"""Biocon"" FDA approval",2024-12-02,0.0006722960020706152,0.8531434796386115,0.010433179316208364,0.010327187387391865,0.04005707840243516,0.03891943432532656,0.015523484671181698,0.015380366240954697,0.014257916692501173,0.014149790705710874,-0.008431866267624533,-0.008437289665745733,0.010301868424005923,0.009918836912699024,-0.0028356374026026624,-0.002843643706948263,0.01258059981486053,0.01245943225590853,-0.01683741585082346,-0.01690663484831346,0.00665339213067482,0.00657227266494692,-0.0209617016685755,-0.021346799785249202,0.07183979281470186,0.07033948899363826,-0.021400762976466276,-0.022065373419655476
Biocon,NSE,Unknown Drug,Unknown Drug,2025-01-07,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5920454545454545,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",Google News Enhanced,"""Biocon"" FDA approval",2025-01-07,0.0006722960020706152,0.8531434796386115,-0.008011539458455091,-0.008032049853087992,0.009536356525306081,0.009492050620287082,0.008503826580521116,0.008431610693648416,0.0005842874006626655,0.0005264502102501657,-0.021451866729845875,-0.021917166300144977,0.046612006077713375,0.044417634181347074,-0.023179567669208815,-0.023613222603473014,-4.852177678530377e-05,-4.94298707738039e-05,-0.009458282589362675,-0.009810355689584976,0.017844945860957556,0.017776166045588557,0.03889830917690895,0.037082867403493355,-0.010838935681811103,-0.011499104629047305,0.024056883002509716,0.021386025285250118
Biocon,NSE,Pharma Gets Usfda,Pharma Gets Usfda,2025-03-24,Good,0.3,0.0454545454545454,https://news.google.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?oc=5,0.5501797094790878,Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",Google News Enhanced,"""Biocon"" FDA approval",2025-03-24,0.0006722960020706152,0.8531434796386115,0.007427813474389464,0.006939600724621263,-0.0006722960020706152,-0.0006722960020706152,0.00793349325541082,0.0076023410895456195,-0.008948832373080168,-0.008951574052678168,-0.003045405163849855,-0.0030838559619937554,0.007689135406746193,0.007576088440205692,0.007779283697163933,0.007773852122453833,0.0037817277548467584,0.0037816349524355582,-0.0012903139575811502,-0.0013216486257431508,-0.0047747898979778386,-0.00483732274454654,-0.0021466801818929796,-0.0021757763888972798,0.002694773190799646,0.0018342157974243437,0.003349227414558723,0.00322073931570242
Biocon,NSE,Jobevne,Jobevne,2025-04-10,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5470454545454545,Pharma stock in focus: Biocon arm announces USFDA approval for Jobevne - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Pharma stock in focus: Biocon arm announces USFDA approval for Jobevne</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",Google News Enhanced,"""Biocon"" FDA approval",2025-04-09,0.0006722960020706152,0.8531434796386115,0.003534265208974671,0.0034966430212324713,-0.002641216318531663,-0.0026993032595410624,-0.017830478314451288,-0.019226661991790885,-0.03218583684319688,-0.03418640399812027,0.024774786424835854,0.023652410613699652,-0.026541155005033172,-0.02781574084918207,0.013174634315511802,0.0126269016044398,0.012556836868800821,0.011820926033984724,0.001103431594862033,0.0011030158373906331,-0.007083584594528745,-0.007104825429747145,-0.0016773718106283184,-0.0016790098552705182,-0.024348479842369306,-0.028963315614520098,0.01807394637401759,0.01676700819079749
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2015-11-25,Bad,0.0,0.0909090909090909,https://news.google.com/rss/articles/CBMisAFBVV95cUxQOTlnNDhBNVBsXzRaYmNseWEyOHpQVHpxdGpDZlBWZUh3XzJ6SkxzMkxjeG1XVm5OanZBTWZ4RVRDTHhaOHhyWFhEUW1Ca0xkempOeGkzdE44TTU3cVB2OFFTd2dTdEZvWWdNb2l0YjNtYVhpamVWcmpsRmJUWW5xQkdYYlhFZnRqOEhzQ0JHYTJTOG1reHgzWEFXa0dRR2dabm9ZZFd3allkSTN5Rm9QYg?oc=5,0.4840909090909091,Premium: US FDA Warning Letter to Dr. Reddy’s – Here is an Additional Update - Capitalmind,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQOTlnNDhBNVBsXzRaYmNseWEyOHpQVHpxdGpDZlBWZUh3XzJ6SkxzMkxjeG1XVm5OanZBTWZ4RVRDTHhaOHhyWFhEUW1Ca0xkempOeGkzdE44TTU3cVB2OFFTd2dTdEZvWWdNb2l0YjNtYVhpamVWcmpsRmJUWW5xQkdYYlhFZnRqOEhzQ0JHYTJTOG1reHgzWEFXa0dRR2dabm9ZZFd3allkSTN5Rm9QYg?oc=5"" target=""_blank"">Premium: US FDA Warning Letter to Dr. Reddy’s – Here is an Additional Update</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Capitalmind</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2015-11-24,-0.0003823888278526971,0.9648408844569466,-0.018890969121251135,-0.019080613166299835,-0.019006455187182594,-0.019243265244419695,-0.01500618876532714,-0.015336893625105241,0.023011481207153014,0.022774179058273114,0.012819959754889369,0.012681297222219567,0.0026340586829334805,0.00261399747118208,-0.07381843671387964,-0.07762216770942554,-0.00505247579605235,-0.00505258518099775,0.009403089824182188,0.009397144149733389,0.01856593395768587,0.018050747088779875,0.004288549640884522,0.004208691628055221,-0.017072172111718485,-0.018205295755332095,-0.04661333908717941,-0.051018170023854795
Dr. Reddy's,NSE,Zembrace,Zembrace,2016-02-01,Good,0.3999999999999999,0.0454545454545454,https://news.google.com/rss/articles/CBMi2wFBVV95cUxQdU12R2VTOVBWNFg0SDk2RWZXUTJBbktnZUdzY3R0TkxKRzBvQmV4V2V5bFhqdExVYlBuTG1Lc05ZbEtXM1JfZVNIdC1xRkxoTEJYaVJBc2pSazJmY1hodUN2aWtqeWl4Z1l2X3I0MVNUbGF5X2d0NUpIN2FoMVJfbXFRRC04a2I0U3lKcGllLTFRNlpZMWk0QUdxR0h6X21JWEg5MDZfYlhhcm50V3doekpuSzBtNUNwVFNobXhDOFp1TWdPODI3a2xuak85MEpST3FNT3ctR25LMHc?oc=5,0.5470454545454545,Dr. Reddy's Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) Injection for the Acute Treatment of Migraines in Adults - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQdU12R2VTOVBWNFg0SDk2RWZXUTJBbktnZUdzY3R0TkxKRzBvQmV4V2V5bFhqdExVYlBuTG1Lc05ZbEtXM1JfZVNIdC1xRkxoTEJYaVJBc2pSazJmY1hodUN2aWtqeWl4Z1l2X3I0MVNUbGF5X2d0NUpIN2FoMVJfbXFRRC04a2I0U3lKcGllLTFRNlpZMWk0QUdxR0h6X21JWEg5MDZfYlhhcm50V3doekpuSzBtNUNwVFNobXhDOFp1TWdPODI3a2xuak85MEpST3FNT3ctR25LMHc?oc=5"" target=""_blank"">Dr. Reddy's Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) Injection for the Acute Treatment of Migraines in Adults</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2016-02-01,-0.0003823888278526971,0.9648408844569466,0.02459038894708861,0.023588750637357814,-0.006015460029499238,-0.006041621855332238,0.00410593179462438,0.0038218779217333784,0.008866226091677008,0.008784377564803807,0.008507032240260452,0.008027683512485253,-0.009629514462992737,-0.009787652689974138,0.022159120058325002,0.0221589051075096,-0.0009326472394352754,-0.0010203674301532753,-0.003214154928109278,-0.003214161705640278,0.011075668592394314,0.010530423428775419,0.0014674586546291404,0.0013891384685284416,0.04005411904415121,0.03818106778104802,0.030555445137803904,0.029843937869019906
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2017-01-24,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMivwFBVV95cUxPaUtjNnE4X0UwbTF2NWlRR3A5MGgzZFVIZm4wX1Z5M3NZWmJyb09QRFRtQmxjdmd2TWZ3alZUeV9nWjFUbWZDc0tJU3R2TzFXRXc4OWdFd3otVlYzTXRvM3dJemVQWFZLU0JzRTN2Wll1ZmpmYUl0VHZuSWl6aE5OYmV0YXRBZ254MlVXdEhMa2owMWVqLVR4MDJzM3R5OUJuRmlSTXFJMHZwTkp0ckFQZHQ5ZkRPUi1EamJRZVcySQ?oc=5,0.5470454545454545,"Mezzion sues Dr. Reddy's for fraud, citing plant problems that cost it a drug approval - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxPaUtjNnE4X0UwbTF2NWlRR3A5MGgzZFVIZm4wX1Z5M3NZWmJyb09QRFRtQmxjdmd2TWZ3alZUeV9nWjFUbWZDc0tJU3R2TzFXRXc4OWdFd3otVlYzTXRvM3dJemVQWFZLU0JzRTN2Wll1ZmpmYUl0VHZuSWl6aE5OYmV0YXRBZ254MlVXdEhMa2owMWVqLVR4MDJzM3R5OUJuRmlSTXFJMHZwTkp0ckFQZHQ5ZkRPUi1EamJRZVcySQ?oc=5"" target=""_blank"">Mezzion sues Dr. Reddy's for fraud, citing plant problems that cost it a drug approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2017-01-24,-0.0003823888278526971,0.9648408844569466,-0.004269707092074396,-0.004274011141461396,-0.004590935802932363,-0.004637069773152764,0.0011877276295445861,0.0011842215564387862,0.009327131571387275,0.009324179639261375,-0.009116152833677907,-0.009148793160989807,0.007674727609059974,0.007531858717003475,0.0007873116271398433,0.0007576749253415428,-0.0013908297924035704,-0.0013910004738107704,0.003203592700107196,0.003175505486777596,0.010223131924689675,0.010222963773636375,-0.0025307384447544397,-0.00254779957505834,-0.007461936527752804,-0.007551472879903806,0.010292468014778705,0.010217344136886405
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2017-05-01,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMigwFBVV95cUxPVHhON19NWWszNEVxZENzUFFxZUE3VlNOUVFPWUVpTzdSSDFQYmphN2V3OFBFOVE0WEdjUVdkVkt2TWZKMk9Remd3NEVQY2dhejZqOUtVX3ZTTzQ5QXNISi0xdTRMRnRqNTd6MnQyQmdrSnYzdnVWa0ZtaDc4ckF4eW03OA?oc=5,0.4270454545454545,FDA cites third Dr. Reddy's plant this year - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxPVHhON19NWWszNEVxZENzUFFxZUE3VlNOUVFPWUVpTzdSSDFQYmphN2V3OFBFOVE0WEdjUVdkVkt2TWZKMk9Remd3NEVQY2dhejZqOUtVX3ZTTzQ5QXNISi0xdTRMRnRqNTd6MnQyQmdrSnYzdnVWa0ZtaDc4ckF4eW03OA?oc=5"" target=""_blank"">FDA cites third Dr. Reddy's plant this year</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2017-05-02,-0.0003823888278526971,0.9648408844569466,0.007515132015049062,0.007514403998425861,-0.021013215955286824,-0.02109302714447372,0.0018174234530115956,0.0017276328633536956,0.001446719924672035,0.0014320814188284355,0.0034127926738115487,0.0034122916994645492,0.005584599693290957,0.005564364797507256,0.02183071427357778,0.02181818516311608,-0.005356006435417822,-0.005364012591539723,0.005992326190482695,0.005991662856541995,-0.009028303840929832,-0.009028765310468333,-0.004011359656417829,-0.004039181260253729,-0.0068211478887425835,-0.007006617164401179,0.00942737053129499,0.009377888857396292
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2017-10-20,Bad,0.0,0.1363636363636363,https://news.google.com/rss/articles/CBMiwAFBVV95cUxQRTV1Vm10VU1FRENRLVhSX0l4NWVCRTJDRkRhZUQ3alFIdHBZNy1Mc1hqcjg1R1h6ZVgwM09vMVlsbVV2MWxFeDRsUXBRZHBKNW43X3VCTXVPa2NyWl9NbVZ6VHBCWHhLM2lVOTlVRXlWM3ZaTEtXaTR4bzlzRnBTd05UWnp5dWd6UmhHN1VhVHlaQi15RE45UE1oSXVnaTN0bVdrUTZ2dGhPdkNIT0xvTkZJakpZZWF6NThGdFNrMFU?oc=5,0.5061363636363636,"Dr. Reddy's, fighting to recover from FDA warning letter, recalls 500K heartburn tablets - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxQRTV1Vm10VU1FRENRLVhSX0l4NWVCRTJDRkRhZUQ3alFIdHBZNy1Mc1hqcjg1R1h6ZVgwM09vMVlsbVV2MWxFeDRsUXBRZHBKNW43X3VCTXVPa2NyWl9NbVZ6VHBCWHhLM2lVOTlVRXlWM3ZaTEtXaTR4bzlzRnBTd05UWnp5dWd6UmhHN1VhVHlaQi15RE45UE1oSXVnaTN0bVdrUTZ2dGhPdkNIT0xvTkZJakpZZWF6NThGdFNrMFU?oc=5"" target=""_blank"">Dr. Reddy's, fighting to recover from FDA warning letter, recalls 500K heartburn tablets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2017-10-19,-0.0003823888278526971,0.9648408844569466,-0.00960888903579533,-0.009614145810043028,-0.002929092040869769,-0.0029864566900287704,0.0027710458368770848,0.0025570068237217858,-0.014777565644055973,-0.014820294093656672,0.0088589812758179,0.0088575366556304,0.004402037570156179,0.00438858902734258,0.0074716112543727845,0.0074674368244781845,0.0001155017637309633,0.0001149207300802633,0.0018343255137272668,0.0018146398637382665,-0.006209743972231417,-0.006211581448599417,0.011165435983054939,0.010935804436792538,-0.01568551960802609,-0.016006353114376284,0.014377130542654536,0.014121220406489835
Dr. Reddy's,NSE,Buprenorphine,Buprenorphine,2018-05-15,Good,0.0,0.0454545454545454,https://example.com/drl-suboxone-approval,0.5395454545454546,DRL Announces FDA Approval for Generic Suboxone,Dr. Reddy's Laboratories (DRL) receives FDA approval for generic Suboxone (buprenorphine and naloxone) tablets.,Comprehensive Sample Data,DRL FDA Approval,2018-05-15,-0.0003823888278526971,0.9648408844569466,0.005094140448095693,0.005090678845775593,-0.0013258302845596155,-0.0013389235120877157,-0.018443561239097753,-0.019115408212575152,0.014515645475832221,0.014515543192554822,0.005237234821613925,0.005144373654772725,-0.0009489862812333016,-0.0009595260224441022,-0.007881216099181557,-0.007907582612376557,-0.010239599697048338,-0.010275295965865438,0.007879044910717836,0.007876040984700036,-0.004144208659359203,-0.005182451787821701,0.026107088010133943,0.024286181178777046,0.005077629221884471,0.004296263968440272,0.011721108465262683,0.008796891797413385
Dr. Reddy's,NSE,Suboxone,Suboxone,2018-06-15,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5470454545454545,Dr Reddy’s gets US FDA approval to launch Suboxone generic | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dr Reddy’s gets US FDA approval to launch Suboxone generic | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2018-06-15,-0.0003823888278526971,0.9648408844569466,0.007118723983609472,0.005916089518147573,0.004532173787501301,0.004484070782286301,0.025841569226218063,0.02455539829754096,0.019655989596919415,0.019215715203270214,-0.004458729738794358,-0.004475518984532358,0.012632691211506782,0.012018810256262686,0.013152820764037275,0.013036652349201075,0.014129322692286648,0.014124841158249048,-0.01705694251444426,-0.01711300480204026,-0.007103562861326107,-0.007342186885487706,-0.011820803777410599,-0.0118573118262494,0.05268972685545389,0.04969575481671269,-0.00869916569685704,-0.009151010006327242
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2019-02-14,Bad,0.35,0.1363636363636363,https://example.com/drreddys-warning-letter,0.4936363636363636,Dr. Reddy's Receives FDA Warning Letter for Srikakulam Facility,FDA issues warning letter to Dr. Reddy's Laboratories for current good manufacturing practice violations at Srikakulam facility.,Comprehensive Sample Data,Dr. Reddy's FDA Warning Letter,2019-02-14,-0.0003823888278526971,0.9648408844569466,-0.005202474438418188,-0.005266269217618789,-0.016608071060689664,-0.016673768785986965,-0.008658055299886705,-0.008830630342452605,-0.03059305193912682,-0.03220608003950692,0.0043018992323191774,0.0042019573388668765,0.0018368457663073233,0.0018214417208842239,0.0004151131204104472,-0.0003638939351249537,0.012152357388794116,0.012151989331325117,-0.011885418991506403,-0.011948239744059603,-0.011220332550950772,-0.011231092054099672,0.010045328010371543,0.009756758294212246,-0.0567597535058022,-0.058774791046698395,-0.0004929530228810694,-0.001634478107746867
Dr. Reddy's,NSE,Us After Fda,Us After Fda,2019-07-23,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5470454545454545,Dr Reddy's launches insomnia treatment tablets in US after FDA approval - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxPa2JMLVBtRENXX1puNGVDVDVTSUtVQzV6VkZOMW5nTmRNZkM1TXFSaW1CVjh6OElOd1BBSGxYbmRCalBvWm02bF9LeWhzNFRidS1ndEp0TGg0V1cyeFZ2eU1zYm8yQUxkZkI4dDN2cnlYeWpNMGQ5ODBMX1JBYlM5QWhHbjUwbDliLVJodUJMcnh0VVMyeHFFMmJaT0kyNTExV2t1ZXYySE1RQTlUYXhhMGdkTDNrTXVpZHNPbU1vdGZaaXpJ0gHKAUFVX3lxTE9zNzZzMndZc3poNzNNUDhnNnFKN0JWRHZoSTBNeEtDQ09UZ3lQeUN6eXVtRDF4Y0hvdEM4OGpDM1NYZlFxdk1ZMS1vYlppN0h4VmhhV0NCcDRtSWcwMUxKNjZ4bmduc3hZNnRLdVA3clNmWGNxSmpsdE9UMk5KSnFnbXd4U053aHFBU0hEeWUzeGhmbXdrSGJzSlRtTEFoRmxXX05OYjZNTHJMT1k3cWdrN3pTb0JPS0doQ0x3MkN6OVVvclRYTzNzU0E?oc=5"" target=""_blank"">Dr Reddy's launches insomnia treatment tablets in US after FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2019-07-23,-0.0003823888278526971,0.9648408844569466,-0.001799334007055873,-0.0019703805121414723,-0.005708353003927402,-0.005715633073492402,-0.0002702331169547995,-0.0002783830332772001,0.021025768992805543,0.02089693268581744,-0.009685604257769763,-0.009712885495285963,-0.002223841416553237,-0.002303801309481138,0.008802195089971352,0.008802188445206652,0.005444260977124818,0.005223066365589019,0.006938911314755963,0.006757687401685163,0.00048100240750087106,0.00030099135372256905,-0.004185579591741609,-0.004827350965614707,0.0035622446070977063,0.0032196505716204048,0.017480790197611396,0.016256582600588695
Dr. Reddy's,NSE,Nexium On Quality,Nexium On Quality,2020-05-12,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMitAFBVV95cUxNa3pIVzNmWDVraDJRZ19tYUZpNHAtcGYyMmNRRUVuOUc3bUhxZHMyeF9lMlRGY2UzOWlxTTMtcEY0Rlo2VHY5RUhPTFVidllJWElGUzQxaUl3SWJybThncF83TEJSdDNQLXlmdjZXVDlhMWZseW54VUFJMzc0ZTg2RjJUSndmd21MXy1QT0EtVU84SFB4NE0zNmtqWC1XV2pKcGpUaXBQcUdXcEE4akVrWTVib28?oc=5,0.4720454545454545,Dr. Reddy's Laboratories recalls bottles of generic Nexium on quality concerns - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxNa3pIVzNmWDVraDJRZ19tYUZpNHAtcGYyMmNRRUVuOUc3bUhxZHMyeF9lMlRGY2UzOWlxTTMtcEY0Rlo2VHY5RUhPTFVidllJWElGUzQxaUl3SWJybThncF83TEJSdDNQLXlmdjZXVDlhMWZseW54VUFJMzc0ZTg2RjJUSndmd21MXy1QT0EtVU84SFB4NE0zNmtqWC1XV2pKcGpUaXBQcUdXcEE4akVrWTVib28?oc=5"" target=""_blank"">Dr. Reddy's Laboratories recalls bottles of generic Nexium on quality concerns</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2020-05-12,-0.0003823888278526971,0.9648408844569466,-0.0035340322740810524,-0.0038964558210821502,0.0012826961897583347,0.0012709656005391355,0.0025110841065694067,0.0025036359396928064,0.005568585360513571,0.00485940975611087,-0.010011314941773652,-0.01048997917354465,-0.0077605488439511094,-0.008027800117565608,0.015310203350328967,0.015308855037738467,-0.00871797737172049,-0.008797952364395088,0.01251179785590354,0.01251145303669684,-0.007297758207914993,-0.007411085815339994,-0.0012784423480411778,-0.0012938331883549778,-0.004182981559013392,-0.005752423698283989,0.01052782327855585,0.010317436706345245
Dr. Reddy's,NSE,Revlimid,Revlimid,2020-08-26,Good,0.0,0.0454545454545454,https://example.com/drreddys-revlimid-approval,0.5395454545454546,Dr. Reddy's Receives FDA Approval for Generic Revlimid,Dr. Reddy's Laboratories gets FDA approval for generic version of Revlimid (lenalidomide) capsules.,Comprehensive Sample Data,Dr. Reddy's FDA Approval,2020-08-26,-0.0003823888278526971,0.9648408844569466,-0.005759174943395307,-0.005783027017406007,0.002062949432791395,0.0020585849460570947,-0.003640494936892304,-0.003645203714899004,-0.0013711007128355303,-0.00137845747142253,0.0025499396400725603,0.002499321969552661,-0.0026774634144316016,-0.002678729882509002,-0.0028019281258540142,-0.002802056791298714,-0.023568401506631004,-0.023669198654354105,0.01657849401164152,0.01625926408298722,-0.011447067401191148,-0.01165353285739465,0.00011245605115920671,0.0001124391539113067,-0.006157881520259185,-0.006248781288117787,-0.02112644697087544,-0.021753085066148942
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2021-12-03,Bad,0.0,0.0909090909090909,https://example.com/drreddys-hyderabad-inspection,0.4565909090909091,FDA Inspection at Dr. Reddy's Hyderabad Facility Concludes,FDA concludes inspection at Dr. Reddy's Laboratories Hyderabad facility with observations under Form 483.,Comprehensive Sample Data,Dr. Reddy FDA Inspection,2021-12-03,-0.0003823888278526971,0.9648408844569466,0.03006043755882561,0.029472175408681214,-0.001835584325593092,-0.0018989911310132931,-0.0003201685960690136,-0.00033092056362831346,-0.015371550419923816,-0.015483120650195716,0.0024466186534693474,0.0023722673144779462,-0.0026224966661116574,-0.0027244017915655575,-0.0015600749798921378,-0.0017896949947462382,0.0004399049143765316,0.0004279860855216323,-0.018282829518700847,-0.018343547355502546,0.011219117531145913,0.011205890076006714,0.00021167174349911048,0.0002116503772511105,0.014979752870709037,0.014131410378321838,-0.00797221030957143,-0.008287715811469325
Dr. Reddy's,NSE,Laboratories Gets Fda,Laboratories Gets Fda,2022-02-09,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNElWamNGWUpCWmwySTV5OVlEOGFvRFQxLVlXejdheWZNZ05CMHhTVWUzdmdZWF9fQktQZ19qaDFVX2JlYVVnWkhXc2oycEl2OVhVZHhpX1ViYVN2b0RYRGl0aE5WSW9ua1VPbUhGWmg2WkFqSS1LcG1fUVVmRno5Z1d3QWlFVURRbko4cUhBenk0cy1GdWkxNklxcGFJTkdhVDlSMllWSFRlYjDSAbMBQVVfeXFMUFJ2RVF2S0VBeGpkRnFnQ3BBaDJDMlkxeW8yTjJLQVk5enlEUjVjamxjeHQ0Tmd5RGVxYzVnd1NIODR6ZDZiMEhvUWNKd2s0VlR3dGtaY3I1enZja0ZjcVVkdnFEdXVMYkk3M2NLN3FNOFVMRnpGZjJSNUlLeGJEVnF3ZWJFTTg0VTdjYUJRR29Bd1EwOUZYbFB5VVdVX0RweWVwLTIyWUVhOEsxdEQ1anZWdmc?oc=5,0.5470454545454545,"Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market - NDTV","<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNElWamNGWUpCWmwySTV5OVlEOGFvRFQxLVlXejdheWZNZ05CMHhTVWUzdmdZWF9fQktQZ19qaDFVX2JlYVVnWkhXc2oycEl2OVhVZHhpX1ViYVN2b0RYRGl0aE5WSW9ua1VPbUhGWmg2WkFqSS1LcG1fUVVmRno5Z1d3QWlFVURRbko4cUhBenk0cy1GdWkxNklxcGFJTkdhVDlSMllWSFRlYjDSAbMBQVVfeXFMUFJ2RVF2S0VBeGpkRnFnQ3BBaDJDMlkxeW8yTjJLQVk5enlEUjVjamxjeHQ0Tmd5RGVxYzVnd1NIODR6ZDZiMEhvUWNKd2s0VlR3dGtaY3I1enZja0ZjcVVkdnFEdXVMYkk3M2NLN3FNOFVMRnpGZjJSNUlLeGJEVnF3ZWJFTTg0VTdjYUJRR29Bd1EwOUZYbFB5VVdVX0RweWVwLTIyWUVhOEsxdEQ1anZWdmc?oc=5"" target=""_blank"">Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2022-02-09,-0.0003823888278526971,0.9648408844569466,0.007959056404395606,0.007661975630671707,-0.007833362627263588,-0.007876110410523088,-0.006063446354986691,-0.006076955732803091,-0.010081100967404905,-0.010129666796237205,-0.004435316703960358,-0.004439685401481057,0.005857393962187616,0.005799186696642015,0.0006406728983694905,0.0006405732849522905,-0.0009047444903175789,-0.00095883024702338,-0.005527210699715582,-0.005924616986981782,-0.0007496339492364112,-0.0008984277679117102,0.011100066091431823,0.011058965100219423,-0.020454170249219937,-0.020860442710372733,0.004559149850531741,0.003917663383254842
Dr. Reddy's,NSE,Revlimid,Revlimid,2022-09-08,Good,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMisgFBVV95cUxNeXg3cFVZLU40RjIxZDUzUlRuQ1VXRzk2RHo1bUMxX2FhRHNxTTJsYUVURGxuRnNKc1c1ZS15R19ING9JaGhwcDl5SWVzYU5lVHRQR09uRER0UEhkeldNUmx2Y011X2hnTnZ0MVN6MWVKQmlINHJXWnBFT0RHdTlUcW5XSU9rV05ENlM1b09oVjFOTk9aVGtGYzNJNjBVdThnMTVWaVhNek91WUFMX3dLekJn?oc=5,0.5470454545454545,"Dr. Reddy’s Launches, Cipla Receives Approval for Generic Revlimid - Managed Healthcare Executive","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNeXg3cFVZLU40RjIxZDUzUlRuQ1VXRzk2RHo1bUMxX2FhRHNxTTJsYUVURGxuRnNKc1c1ZS15R19ING9JaGhwcDl5SWVzYU5lVHRQR09uRER0UEhkeldNUmx2Y011X2hnTnZ0MVN6MWVKQmlINHJXWnBFT0RHdTlUcW5XSU9rV05ENlM1b09oVjFOTk9aVGtGYzNJNjBVdThnMTVWaVhNek91WUFMX3dLekJn?oc=5"" target=""_blank"">Dr. Reddy’s Launches, Cipla Receives Approval for Generic Revlimid</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2022-09-08,-0.0003823888278526971,0.9648408844569466,0.009767199619847735,0.009715667640501835,0.005667381131684144,0.005663192779557444,0.0017967981843591656,0.0017800451309407652,0.003692848504730092,0.0036753917190936914,-0.010954115935310507,-0.010956949734356906,0.005880977738579221,0.005867194076542321,-0.002788604464918983,-0.002796129314894783,0.0006878124734926051,0.0006868027152926052,-0.0016596643137524335,-0.0016615408195523335,-0.005447413644371093,-0.005489176600994093,0.002664134974305286,0.0026063275714345857,0.00997011150531063,0.009877347535736828,-0.006543734975244618,-0.006653716448714018
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2023-03-07,Good,-0.1666666666666666,0.0454545454545454,https://example.com/drreddy-facility-clearance,0.5195454545454545,DRREDDY Receives FDA Clearance for Manufacturing Facility,Dr. Reddy's (DRREDDY) receives FDA clearance for its manufacturing facility after addressing previous observations.,Comprehensive Sample Data,DRREDDY FDA Clearance,2023-03-06,-0.0003823888278526971,0.9648408844569466,-0.013090090896590528,-0.013213188106430027,-0.012190921051475219,-0.012474212452785018,0.006619102523772149,0.006598748427693549,0.010784521976385854,0.010727883935162255,0.00421536774257599,0.00415763081807829,-8.971515542712189e-05,-8.975481018352194e-05,0.004963225974777871,0.004958962858330772,-0.005307860453641712,-0.005360592552317411,0.0018247826950803406,0.0018192418351771406,0.005038225484868193,0.005021793898285093,-0.003382992202467444,-0.003394408446538644,-0.003662019705331754,-0.004203137378280951,0.003135381498617249,0.0030449975929369506
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2023-11-30,Bad,0.0909090909090909,0.0454545454545454,https://news.google.com/rss/articles/CBMioAFBVV95cUxNbXNEV0t4V0YyV0t6dXM3MTVNOGo3bGpIUFhpWHlhU3FDNDdnUExfZFBNS25jY3BHT01EaGJsNWxEeHUzeE5aM05OMW9JWElQbHRPLTBUQ05ac2tRWUZfVUVlZDdIZzA5RmlrY0ltZzlWQXNTcFFvVXE3ckM5cUdKa1lwcjRNdXRkXzQ4cnFFT3hjNTlrUGF1UkpWR3hKWlJX?oc=5,0.4270454545454545,Dr. Reddy's scolded for maintenance shortfalls in new FDA Form 483 filing - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNbXNEV0t4V0YyV0t6dXM3MTVNOGo3bGpIUFhpWHlhU3FDNDdnUExfZFBNS25jY3BHT01EaGJsNWxEeHUzeE5aM05OMW9JWElQbHRPLTBUQ05ac2tRWUZfVUVlZDdIZzA5RmlrY0ltZzlWQXNTcFFvVXE3ckM5cUdKa1lwcjRNdXRkXzQ4cnFFT3hjNTlrUGF1UkpWR3hKWlJX?oc=5"" target=""_blank"">Dr. Reddy's scolded for maintenance shortfalls in new FDA Form 483 filing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2023-11-30,-0.0003823888278526971,0.9648408844569466,-0.0013310685308464305,-0.0013361951292361306,0.0012545786290260436,0.0012483932667195436,0.0005018959980194843,0.0005018607172184843,0.008122635973941764,0.008108895195373365,-0.0028556104716446215,-0.002879775076149421,0.0005910139747250711,0.0005105715039826712,-0.008747516855250744,-0.008770026608797044,0.0011871698123107454,0.0011865115538918453,-0.002675980573790816,-0.002682277243800216,-0.0016672282065499575,-0.0016992456648136575,0.004661309179266742,0.004615952945710342,0.005692431598496239,0.0056431789739258414,-0.0072422466440140295,-0.007349085017808731
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2024-02-12,Bad,0.0,0.0454545454545454,https://news.google.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?oc=5,0.4470454545454546,Dr Reddy's Laboratories R&D facility gets VAI status in USFDA inspection - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dr Reddy's Laboratories R&amp;D facility gets VAI status in USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2024-02-12,-0.0003823888278526971,0.9648408844569466,-0.01579875225892862,-0.01583989455490392,-0.009774202082946711,-0.009843729299460311,0.006169759256972212,0.006167488831815912,0.0036386844407036117,0.0036335925636603117,0.0032594689982034537,0.0032592365033135536,0.027914643652316846,0.027506071909396447,-0.0016468386101201587,-0.0016468812279358586,-0.008732943690435525,-0.008807406940808025,-0.0010919229855674692,-0.0010923379651320694,-0.007345106259982276,-0.0073979486107283755,0.002120421025179642,0.0019964330394512415,-0.012505041645996055,-0.012623305955574458,-0.016696390520925787,-0.01694814170515309
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2024-06-25,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMipAFBVV95cUxOX2VjMVlJaUxJTUxIbVR6dmZvbnlQbF9YYk0wb0NCQXR5Q3lCNUVuRV9TOHhyMXltV0pKWW9TRnFNSDdLTnpuR0dNZ2R1N096TkVKNU1Da1VON3BnTTFPNHNxajExSVljZmVQZWdrR0ljMTlhVTAxRVhuMWFDVUJKMDB0TTItZjFSQVNDOHdycjJBYXU1OVBFaFBWLXJ3TUhvRVhqbg?oc=5,0.4270454545454545,FDA slams Dr. Reddy's plants in India with a pair of Form 483s - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOX2VjMVlJaUxJTUxIbVR6dmZvbnlQbF9YYk0wb0NCQXR5Q3lCNUVuRV9TOHhyMXltV0pKWW9TRnFNSDdLTnpuR0dNZ2R1N096TkVKNU1Da1VON3BnTTFPNHNxajExSVljZmVQZWdrR0ljMTlhVTAxRVhuMWFDVUJKMDB0TTItZjFSQVNDOHdycjJBYXU1OVBFaFBWLXJ3TUhvRVhqbg?oc=5"" target=""_blank"">FDA slams Dr. Reddy's plants in India with a pair of Form 483s</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2024-06-25,-0.0003823888278526971,0.9648408844569466,-0.004951000013892093,-0.0050715523346962915,-0.003822111717206458,-0.0038392911135924582,-0.0011102428933506205,-0.0011132425153578206,0.003100016576542822,0.0030769463345326218,0.002574384804326693,0.002548329434254393,0.0034796683672490376,0.0034721875817690377,-0.016186925284019774,-0.016187869782531877,0.02543334940014828,0.02506674949925148,0.012915246994164138,0.01256522388206064,-0.01061382121201146,-0.01064283930781516,0.0021679358066753907,0.0021645492461122907,-0.004208953243579655,-0.004398810194859556,0.013715785704956575,0.012965813537077374
Dr. Reddy's,NSE,Unknown Drug,Unknown Drug,2024-08-12,Good,0.0,0.0454545454545454,https://news.google.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?oc=5,0.5270454545454546,Dr Reddy's Labs gets US FDA clearance: Visakhapatnam facilities classified as VAI - Express Pharma,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dr Reddy's Labs gets US FDA clearance: Visakhapatnam facilities classified as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2024-08-12,-0.0003823888278526971,0.9648408844569466,0.001844429250632544,0.0016023968591164436,0.00788657431662611,0.00788634120174841,-0.00470450755114751,-0.00485541688590441,0.008210495875560058,0.00820900918524746,0.010145170202324187,0.010086856981517388,-0.012487181508909324,-0.012653003473156725,0.006029777509123913,0.005989686057077212,-0.005274287037946381,-0.0055023717975861836,-0.013618859167184555,-0.013619459561837756,0.007576933982178461,0.007428439432938663,0.00045049854940423274,0.0004201340019177333,0.02338216209399539,0.02292918734172529,-0.004835936164424329,-0.005283571867490331
Dr. Reddy's,NSE,Revlimid,Revlimid,2025-02-10,Bad,0.0,0.0454545454545454,https://news.google.com/rss/articles/CBMilwFBVV95cUxQaXBXT2xUQ0huNWNmVjlBRklydEttcTBQM1JKdzRYc0lPSjhCRlRaaHRIYUI4ekttYUdTaXJuUzdKZ0w0WHdva2k1V1ZFLWIyZlBfaWtSdU1UUGltUGpTZ2NzdVFfMzVXLU5sY3ptWE9KSXJ4WXFyU25IZkc4cXhmZ1ZzQjZFOGhpUWM3WU05MW5nVTFNb3ZN?oc=5,0.4520454545454546,Dr Reddy's Gets FDA Nod For Generic Revlimid - BW Healthcare,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQaXBXT2xUQ0huNWNmVjlBRklydEttcTBQM1JKdzRYc0lPSjhCRlRaaHRIYUI4ekttYUdTaXJuUzdKZ0w0WHdva2k1V1ZFLWIyZlBfaWtSdU1UUGltUGpTZ2NzdVFfMzVXLU5sY3ptWE9KSXJ4WXFyU25IZkc4cXhmZ1ZzQjZFOGhpUWM3WU05MW5nVTFNb3ZN?oc=5"" target=""_blank"">Dr Reddy's Gets FDA Nod For Generic Revlimid</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Healthcare</font>",Google News Enhanced,"""Dr Reddy"" FDA approval",2025-02-10,-0.0003823888278526971,0.9648408844569466,0.005267421392620084,0.005267004389800183,-0.0009238957928017905,-0.0010125351025355896,-0.009755889428234748,-0.009775214917841949,-6.413101342737492e-05,-9.147299974077497e-05,0.009223102264598838,0.009218513975579738,0.0010219348202969436,0.0008976953022634439,0.013113102220910975,0.013071148822332174,0.010266227208775887,0.010253764736154088,-0.008288534268030067,-0.008308763264417669,0.003012792907887637,0.0027739235836556353,0.0005251652110563566,0.0005239069995825565,0.003746607422755008,0.0036062953452616073,0.018628753280600787,0.018313980877306783
